February 26, 2007 — A blood test for C-reactive protein (CRP), which is readily available and already used to assess the risk of cardiovascular disease, could be useful in predicting prognosis for men ...

Cancer cells are remarkably good at adapting to stress. When treatments damage them, they often find new ways to survive, ...

In a pooled analysis of the SPARTAN and TITAN trials, statin use during apalutamide therapy was associated with superior overall survival (OS) but also with an increased risk for grade 3 or greater ...

Staging means finding out how far prostate cancer has spread in your body. Physicians group prostate cancers into stages I (1) through IV (4), with stage I being the least advanced and stage IV being ...

Prostate cancer (PCa) is the most prevalent malignancy impacting the male genitourinary system, with approximately 1.6 million new cases and 366,000 deaths reported globally each year 1,2. Factors ...

Symptoms linked to urinary or sexual health often carry an element of embarrassment, making men less likely to discuss them ...

There are around 46,000 new cases of prostate cancer each year in England and Wales, with 13% of these cases showing signs of ...

Novartis launches Pluvicto, India's first approved radioligand therapy for advanced prostate cancer, enhancing precision ...

For prostate cancer patients with low-volume tumors and metastasis, the median overall survival was 37.13 months. Prostate cancer patients with metastatic disease and low-volume primary tumors appear ...

PRESS RELEASEAB SCIENCE PATENT FOR MASITINIB IN THE TREATMENT OF METASTATIC CASTRATE RESISTANT PROSTATE CANCER FORMALLY GRANTED IN THE UNITED ...